ArticleAnnals of medicine2026
Can hyperleukocytosis be caused by a non-hematologic condition? A 10-year retrospective tertiary-care center cohort study.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyperleukocytosis (HL) is defined as a white blood cell counts typically exceeding 100 G/L and is commonly associated with hematologic malignancies. Efforts to identify and characterize non-hematologic causes of HL have been limited and insufficiently addressed in the literature.
methodsWe conducted a retrospective analysis of adult patient records from 2013 to 2023, screened for cases of HL with a primary focus on the characterization of non-hematologic causes.
resultsOut of 878,967 adult patients, 375 patients had HL; 90 were excluded due to opting out of general consent, leaving 285 (median age 66.8 years; 32% female) for analysis. Of these, 276 (97%) had an underlying hematologic malignancy, most frequently chronic lymphocytic leukemia (35.4%), followed by other B-cell lymphomas, acute myeloid leukemia, and chronic myeloid leukemia. Non-hematologic causes accounted for the remaining 3% (
conclusionsThe presence of HL should immediately raise the possibility of a hematologic disease, though a small subset stems from non-hematologic causes. Consequently, HL should prompt immediate peripheral blood smear review and early hematology consultation. Isolated infection-related HL was not observed in this cohort and should be interpreted as a cohort-specific observation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.